Skip to main content
. 2015 Jun 17;10:78. doi: 10.1186/s13023-015-0274-1

Table 2.

Medians and interquartile ranges for lyso-SM-509 in ng/ml for all investigated sub-cohorts

n Lyso-SM-509 in ng/ml
NPC1 patients 110 6.7 (3.4-10.3)
NPC1 carriers 63 0.4 (0.2-0.9)
NP- A/B patients 21 29.4 (14.8-40.0)
NP- A/B carrier 5 0.09 (0.04-0.16)
Healthy controls 43 0.04 (0.03-0.06)